Welcome to LookChem.com Sign In|Join Free
  • or
HENAN SUNLAKE ENTERPRISE CORPORATIONBortezomib High quality Bortezomib//file1.lookchem.com/cas/reactions/2021/05/26/8723817.png
qq

Communicate with Supplier:

Ms. summer
Ms. summer: What can I do for you?

Bortezomib High quality Bortezomib CAS NO.179324-69-7

FOB Price:
USD 750.00-850.00 /Kilogram Get Latest Price
Min.Order Quantity:
1 Kilogram
Purity:
98% purity
Port:
China main ports
Payment Terms:
L/C,T/T,MoneyGram,Other

Add to Inquiry Cart

Product Details

Keywords

  • Wholesale 179324-69-7 Bortezomib used for selective proteasome inhibitor
  • Sale 179324-69- 7 Bortezomib for Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-s
  • 179324-69-7 China suppliers

Quick Details

  • ProName: Bortezomib High quality Bortezomib
  • CasNo: 179324-69-7
  • Molecular Formula: C19H25BN4O4
  • Appearance: light yellow solid
  • Application: 179324-69-7 1>Bortezomib is the first...
  • DeliveryTime: Within 7 working days since received y...
  • PackAge: 1g;5g;10g;25g;50g;100g;500g;1KG;5KG,25...
  • Port: China main ports
  • ProductionCapacity: 20 Kilogram/Month
  • Purity: 98% purity
  • Storage: Room temperature with sealed well
  • Transportation: BY SEA /BY AIR /BY COURIER
  • LimitNum: 1 Kilogram
  • Valid Period: 6 month
  • Certification: ISO/9001 Certificate
  • Usage: Bortezomib is the first proteasome inh...
  • Application: Drug for Cancer treatment

Superiority

1. iso 9001 approved, gmp producing standard,proffesional qa system, our quality is guaranteed.

2. facotory direct sale, most comptive price ensured;

3. audited supplier on lookchem, no trick, no scam!

4. enough stock can make sure safe delivery.

5. complete before and after sale service, welcome your questions and glad to help.

bortezomib

179324-69-7

c19h25bn4o4

Details

product information :

bortezomib

179324-69-7

c19h25bn4o4

bortezomib basic information
drug for cancer treatment
product name: bortezomib
synonyms: velcade;dpba;bortezomib;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;velcade(bortezomib);boronic acid, b-[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;bortezomib for research;bortezomib ( velcade, mg-341, ps-341 )
cas: 179324-69-7
mf: c19h25bn4o4
mw: 384.24
einecs:
product categories: boron derivatives;inhibitors;intermediates & fine chemicals;pharmaceuticals;pepetides;proteasomeinhibitors;apis;inhibitor;final material;api;peptides
mol file: 179324-69-7.mol
bortezomib structure
bortezomib chemical properties
mp 122-124°c
density 1.214
storage temp. hygroscopic, -20°c freezer, under inert atmosphere
stability: hygroscopic and moisture sensitive
cas database reference 179324-69-7(cas database reference)
safety information
hazardous substances data 179324-69-7(hazardous substances data)
msds information
bortezomib usage and synthesis
drug for cancer treatment bortezomib is a drug for treatment of hematopoietic malignancies with the appearance being white or white-like crystalline powder. it is easily soluble in dimethyl sulfoxide, ethanol, but insoluble in aqueous solution. this product is the reversible inhibitor of the mammal cell 26s proteasome chymotrypsin-like activity. 26s proteasome is a large protein complex which can degrade ubiquitin. ubiquitin proteasome pathway plays an important role in regulation of the intracellular concentration of specific proteins in order to maintain the stability of the intracellular environment. proteolytic affects intracellular multi-level signalling cascade. the disruption of the normal intracellular environment can lead to cell death while the inhibition of the 26s proteasome can prevent the hydrolysis of specific proteins. in vitro tests have proved bortezomib exhibits cytotoxicity to multiple types of cancer cells. the in vivo models of preclinical tumor have proved that bortezomib is capable of delaying the tumor growth of multiple myeloma which is suitable for the treatment of multiple myeloma.
the above information is edited by the chemicalbook of dai xiongfeng.
chemical properties yellow solid
usage bortezomib is the first proteasome inhibitor to be approved b the us fda for multiple myeloma, a blood cancer. a reversible inhibitor of the 26s proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. t
usage bortezomib is the first proteasome inhibitor to be approved by the us fda for multiple myeloma, a blood cancer. a reversible inhibitor of the 26s proteasome-a barrel-shaped multiprotein particle foun d in the nucleus and cytosol of all eukaryotic cells. targets the ubiquitin-proteasome pathway.
usage selective proteasome inhibitor

company information :

hennan sunlake enterprise corporation is located in henan province , the central plain of china , which enjoys favorable geogeaphical position and convenient transportion, the com[any was established in june. 1998 , until now having more than 18 years experience in manufacturing & exporting chemical raw material .

sunlake is a professional manufacturer engaged in producing and selling chemicals,including organic & inorganic chemicals , pigments & dyestuffs , water treatment chemicals , food & feed additives and others . these products have been being well exported to europe , southeast asia , the middle east , africa , south america and some other countries and areas.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)